In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...
AbbVie and Neomorph announced a collaboration worth up to $ ... Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more. In a world where ...
1don MSN
The wealth of Dr. Mehmet Oz, the celebrity heart surgeon nominated by President Donald Trump to lead the Centers for Medicare and Medicaid ...
It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...
A sneak peek at upcoming street fairs, festivals, concerts, performances, art shows, library events, community meetings and ...
AbbVie reported better-than-expected fourth-quarter earnings. Strong demand for the company's Skyrizi and Rinvoq autoimmune therapeutics has helped offset the decline in Humira sales since losing ...
AbbVie's Rinvoq and Skyrizi could eventually surpass Humira's peak sales. The dividend is well-funded, though an expensive acquisition spree may lead to slower growth. The stock's solid growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback